FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:278-279 July 28, 1994 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article Related Article PubMed Citation

To the Editor: According to the National Center for Health Statistics, over 300,000 percutaneous transluminal coronary angioplasties are performed annually in the United States¹. Since its approval by the Food and Drug Administration in September 1990, directional coronary atherectomy has been gaining popularity and is increasingly used to debulk atheromatous tissue in coronary arteries². In this procedure, the excimer laser is used to photoablate plaques in coronary arteries. Complications of percutaneous transluminal coronary angioplasty and directional coronary atherectomy include death, myocardial infarction, perforation of the coronary vessel, arrhythmia, stroke, and distal embolization³. We report a case of . . . [Full Text of this Article]

References

Related Letters:

Treatment of Retinal-Artery Embolism
Bartelink A. K.M., Kappelhof J. P., Dickens M. A., Greven C. M., Slusher M. M.
Extract | Full Text  
N Engl J Med 1994; 331:1592-1593, Dec 8, 1994. Correspondence

This article has been cited by other articles:

• Bartelink, A. K.M., Kappelhof, J. P., Dickens, M. A., Greven, C. M., Slusher, M. M. (1994). Treatment of Retinal-Artery Embolism. NEJM 331: 1592-1593 [Full Text]